Dudediligence.

Sarepta Therapeutics, Inc

SRPTNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$417,320

2 notices · 20,426 sh

Nov 2025 to Oct 2026

Reported ·

$417,410

2 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 2 reported sales carry the 10b5-1 box. Together they are 0.02% of the shares on issue.

PLANNED · FORM 144Nov 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-03-12: STEPHEN MAYO, Form 1442025-12-16: IAN M ESTEPAN, Form 1442025-12-16: Estepan Ian Michael, sold2026-03-12: Mayo Stephen, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-03-12STEPHEN MAYO, Director$123,175
7,239 shno plan date144 ↗
Form 4, 2026-03-13: sold 7,239 at $17.02 Form 4 ↗
2025-12-16IAN M ESTEPAN, Chief Operating Officer$294,145
13,187 shno plan date144 ↗
Form 4, 2025-12-18: sold 13,187 at $22.31 Form 4 ↗